Gregory Evan Kraut - Net Worth and Insider Trading
Gregory Evan Kraut Net Worth
The estimated net worth of Gregory Evan Kraut is at least $12 dollars as of 2024-09-20. Gregory Evan Kraut is the Director of Chanticleer Holdings Inc and owns about 36 shares of Chanticleer Holdings Inc (BURG) stock worth over $12. Details can be seen in Gregory Evan Kraut's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory Evan Kraut has not made any transactions after 2017-06-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gregory Evan Kraut
Gregory Evan Kraut Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gregory Evan Kraut owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .
Click here to see the complete history of Gregory Evan Kraut’s form 4 insider trades.
Insider Ownership Summary of Gregory Evan Kraut
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SONN | Sonnet BioTherapeutics Holdings Inc | 2016-09-28 | director |
Gregory Evan Kraut Latest Holdings Summary
Gregory Evan Kraut currently owns a total of 1 stock. Gregory Evan Kraut owns 36 shares of Chanticleer Holdings Inc (BURG) as of June 5, 2017, with a value of $12.
Latest Holdings of Gregory Evan Kraut
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BURG | Chanticleer Holdings Inc | 2017-06-05 | 36 | 0.34 | 12 |
Holding Weightings of Gregory Evan Kraut
Gregory Evan Kraut Form 4 Trading Tracker
According to the SEC Form 4 filings, Gregory Evan Kraut has made a total of 0 transactions in Chanticleer Holdings Inc (BURG) over the past 5 years. The most-recent trade in Chanticleer Holdings Inc is the acquisition of 4 shares on June 5, 2017, which cost Gregory Evan Kraut around $6,600.
Insider Trading History of Gregory Evan Kraut
- 1
Gregory Evan Kraut Trading Performance
GuruFocus tracks the stock performance after each of Gregory Evan Kraut's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory Evan Kraut is -16.99%. GuruFocus also compares Gregory Evan Kraut's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory Evan Kraut within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gregory Evan Kraut's insider trading performs compared to the benchmark.
Performance of Gregory Evan Kraut
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.02 | | | | | |
| Relative Return to S&P 500(%) | -0.88 | | | | | |
Gregory Evan Kraut Ownership Network
Gregory Evan Kraut Owned Company Details
What does Sonnet BioTherapeutics Holdings Inc do?
Who are the key executives at Sonnet BioTherapeutics Holdings Inc?
Gregory Evan Kraut is the director of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include 10 percent owner John Markey , Chief Technical Officer Susan Dexter , and director & Chairman & President and CEO Pankaj Mohan .
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary
Over the past 18 months, Gregory Evan Kraut made no insider transaction in Sonnet BioTherapeutics Holdings Inc (SONN). Other recent insider transactions involving Sonnet BioTherapeutics Holdings Inc (SONN) include a net purchase of 371,600 shares made by Pankaj Mohan , a net purchase of 25,000 shares made by Nailesh Bhatt , and a net purchase of 23,255 shares made by Albert D. Dyrness .
In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 19,539 shares were bought by its insiders, resulting in a net purchase of 19,539 shares.
Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sonnet BioTherapeutics Holdings Inc Insider Transactions
Gregory Evan Kraut Mailing Address
Above is the net worth, insider trading, and ownership report for Gregory Evan Kraut. You might contact Gregory Evan Kraut via mailing address: 60 Center St, Westport Ct 06880.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
